Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs 
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
NY Times Challenges Trump Administration Subpoenas Over Air Force One Report 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
NEW YORK, Jan. 21, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Nobilis Health Corp. (“Nobilis”) (NYSE MKT:HLTH) between April 2, 2015 and January 6, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of Nobilis shareholder. If you purchased or otherwise acquired Nobilis securities between April 2, 2015 and January 6, 2016, your rights may be affected by this action. To get more information go to:
http://zlk.9nl.com/nobilis-health
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Nobilis’ financial statements contained numerous errors concerning the classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results; (2) Nobilis overstated its net income for the year ended December 31, 2014 by more than $4 million; (3) Nobilis overstated its net income for the quarter ended March 31, 2015 by more than $3.27 million; and (4) as a result, defendants’ statements about Nobilis’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
If you suffered a loss in Nobilis you have until March 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
